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Abstract
Background—The prevalence and characteristics of fetal alcohol syndrome (FAS) and partial 
FAS (PFAS) in the United States (US) are not well known.
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Methods—This active case ascertainment study in a Rocky Mountain Region City assessed the 
prevalence and traits of children with FAS and PFAS and linked them to maternal risk factors. 
Diagnoses made by expert clinical dysmorphologists in multidisciplinary case conferences utilized 
all components of the study: dysmorphology and physical growth; neurobehavior; and maternal 
risk interviews.
Results—Direct parental (active) consent was obtained for 1,278 children. Averages for key 
physical diagnostic traits and several other minor anomalies were significantly different among 
FAS, PFAS, and randomly-selected, normal controls. Cognitive tests and behavioral checklists 
discriminated the diagnostic groups from controls on 12 of 14 instruments. Mothers of children 
with FAS and PFAS were significantly lower in educational attainment, shorter, later in pregnancy 
recognition, and suffered more depression, and used marijuana and methamphetamine during their 
pregnancy. Most pre-pregnancy and pregnancy drinking measures were worse for mothers of FAS 
and PFAS. Excluding a significant difference in simply admitting drinking during the index 
pregnancy (FAS and PFAS = 75% vs. 39.4% for controls), most quantitative intergroup 
differences merely approached significance. This community’s prevalence of FAS is 2.9 to 7.5 per 
1,000, PFAS is 7.9 to 17.7 per 1,000, and combined prevalence is 10.9 to 25.2 per 1,000 or 1.1% 
to 2.5%.
Conclusions—Comprehensive, active case ascertainment methods produced rates of FAS and 
PFAS higher than predicted by long-standing, popular estimates.
Keywords
fetal alcohol spectrum disorders; alcohol use and abuse; maternal risk factors; prenatal alcohol 
use; prevalence; children with FAS and PFAS; United States
1. INTRODUCTION
The rate of fetal alcohol syndrome (FAS) in the United States (US) was estimated for many 
years, and believed by many, to be 0.33 to 3.0 per 1000 children (Abel, 1998; Abel and 
Sokol, 1987, 1991; CDC, 1995, 1997; Fox et al., 2015; May and Gossage, 2001; Stratton et 
al., 1996). However, given the lack of active case ascertainment studies (which seek to 
identify cases in a general population) of any fetal alcohol spectrum disorders (FASD) in the 
US and other developed countries (May et al., 2009), many people believed that the above 
estimates were substantial under estimates. FASD are rarely recognized or diagnosed in the 
general population or in general clinical settings (Chasnoff et al., 2015). Therefore, 
surveillance and clinic-based studies are unlikely to produce a true prevalence (Fox et al., 
2015). Active case ascertainment studies undertaken in schools have proven to be accurate 
and to produce high rates of FASD (May et al., 2009). In-school study methods for large 
communities have been employed mostly in South Africa and Italy (May et al., 2000, 2006, 
2007, 2011, 2013a; Urban et al., 2008; Viljoen et al., 2005).
Prior to 2014, only three articles had been published that utilized active case ascertainment 
methods in schools in the US general population. Clarren et al. (2001) reported a rate of 3.1 
FAS cases per 1,000 in a county in Washington State. In that study, only one of the seven 
FAS cases found in the schools had been diagnosed previously. Burd et al. (1999) and Poitra 
et al. (2003) have reported on active case ascertainment methods used in multiple years in 
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Head Start classrooms using a screening tool and follow up dysmorphology exam. Burd et 
al. (1999) reported six cases of FAS out of 1,013 children, 5.9 per 1,000. Poitra et al. (2003) 
included more children from the same community and 4.3 children per 1,000 had FAS. The 
authors do mention that some of the children with FAS identified in the Head Start studies 
had been diagnosed prior to the study, but this community benefited from an active 
dysmorphology consultation service. Many undiagnosed cases of FAS and other FASD exist 
in the US population, and active case ascertainment studies are designed to find them and to 
estimate the true prevalence of FASD.
1.1 Purpose
The purpose of this study was to: 1.) determine the feasibility of using these particular active 
case ascertainment methods in a US community to identify children with FAS and partial 
fetal alcohol syndrome (PFAS) in public and private schools; 2.) ascertain maternal risk 
factors for FASD in a general US population; and 3.) determine the prevalence and 
characteristics of children with FAS and PFAS in this community. Data were collected in 
three samples of first grade students in this Rocky Mountain Region City (RMRC). This 
study was initiated at the invitation of the city/county health department, endorsed by school 
administrators, and approved by the Board of Trustees of the City Schools. The studies 
utilized research methods pioneered in South Africa and Italy.
1.2 The Study Community
The population of RMRC is 59,000 in a county of 85,000. The composition of the 
population is 88.5% White, 5.0% American Indian, 3.8% mixed race, 1.1% Black, and 3.4% 
of Hispanic ethnicity (US Census, 2015). Compared to the US population, the study 
community was more White (+10.8%), less Black (−12.1%), more American Indian (+3.8%) 
and less Hispanic (−13.7%). RMRC residents are predominantly middle class, with average 
economic indicators similar to small cities and counties in the region and state. The averages 
in the county are slightly below US averages on a number of economic indicators: per capita 
income is $24,100 (US average is $28,155), median household income is $43,800 (US = 
$53,000), and 16.5% are below the poverty level (US = 15.4%) (US Census, 2015). Per 
capita alcohol consumption in this state was 2.99 gallons (11.3 liters) of ethanol per year in 
2009 compared to the US average of 2.3 gallons (8.7 liters) (LaVallee and Yi, 2011). The 
overall health rank of this state by the United Health Foundation (2014) is well in the upper 
middle tier, between 20 and 25 of 50 states. County data from the CDC Behavioral Risk 
Factor Surveillance System (BRFSS) indicates less binge drinking overall (13.3%) than in 
either the state (16.9%) or the US (15.5%); however among adults ages 18 – 44, 18.3% 
binge drink which compares to 24.5% for the state (“Western” County, 2011). Heavy 
drinking was reported for this county at 4.9%, compared to 5.9% for the state, and 5.1% for 
the US (“Western” County, 2011). Among adults 18 – 44 years, heavy drinking was 5.6% in 
the County and 6.9% for the State (“Western” County, 2011). Binge drinking among women 
(four or more drinks per occasion) was lower at 14.3% in this state than among males (five 
or more drinks per occasion) at 27.3% (“State” BRFSS, 2013), but bingeing among women 
was 2.2% higher than US averages (12.5%) (CDC, 2013). Therefore, this site has slightly 
lower economic status than US averages, overall good health, but indicators of heavy 
drinking and binge drinking are lower than the home state but higher than US averages.
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The diagnostic criteria used for FAS and PFAS (see Figure 1) were originally set forth by 
the FAS advisory group of the U.S. Institute of Medicine (Stratton et al., 1996), and 
operationalized and updated from clinical experience (Hoyme et al., 2005). The 
classification of the children is based on: (1) specific facial dysmorphology, (2) diminished 
physical stature and/or weight, (3) defined intellectual, developmental, social, and 
neuropsychological assessments, and (4) multiple measures of maternal alcohol 
consumption. Data for all of the diagnostic domains were collected and analyzed by 
members of a multidisciplinary clinical team, each member (physicians, psychologists, and 
interviewers) working blinded to any prior knowledge of the diagnostic findings in other 
parts of the study and the child and family. The data and findings were summarized for each 
child, and structured case conferences were held among the specialists. Highly experienced 
pediatric dysmorphologists/clinical geneticists assigned final diagnoses after considering all 
of the relevant data and the opinions of team members involved in the examination, testing, 
and interview process. The diagnoses considered in this study were: FAS, PFAS, normal/not 
FAS, another known disorder, or deferred for further testing. Due to limited resources and a 
short time frame, the team focused on only FAS and PFAS diagnoses, as these conditions 
exhibit the most clearly defined dysmorphic features in the FASD continuum. Detailed 
numbers of sampling and the flow of the study are found in Figure 2.
2.1 Child Data
The overall study population was all children enrolled in first grade (n=2377) in all of the 17 
elementary schools (15 public and 2 private) during school years beginning in 2007, 2008, 
and 2009. Children who participated in the study did so via active (direct written) parental 
consent. While almost 60% of the parents returned the consent forms for the combined three 
samples (n=1421), 143 checked the box that declined participation; so the total consented 
into the study was 1278 (53.8%) (see Figure 2). The return of forms was lowest in the first 
sample (53%), better in the second (57%), and extra effort by the staff (multiple mailings 
and phone calls) in sample 3 led to a 70% return rate.
Data on the growth, development, and dysmorphology of the children were collected via a 
three-tier method. In Tier I all consented children were screened for height, weight, and 
occipitofrontal (head) circumference (OFC) in their respective schools by project staff. 
Then, if the child had measurements ≤ 10th centile on OFC and/or both height and weight on 
the Centers for Disease Control and Prevention (CDC) growth charts, he/she was referred 
for Tier II screening, a full dysmorphology exam, (n = 588). Because children with FASD 
are often not recognized or identified (Chasnoff et al., 2015), special referrals of children 
experiencing problems in school were also accepted from the teachers (n=10). For the 
dysmorphology exams, all qualifying children were seen by the research team in their 
respective schools (in specially-arranged rooms). Three pediatric clinical geneticists/
dysmorphologists who are highly trained in and experienced with FASD diagnoses provided 
the exams. Each child was examined individually and independent of any prior knowledge 
(e.g. reason for entry to the study). Each physician-led team collected independent measures 
of growth, physical development, and dysmorphology and recorded them on a structured 
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inventory form for child data salient to FASD and other known birth defects. This form 
includes a weighted FAS dysmorphology score (Hoyme et al., 2005). In the first sample of 
this study, each child received identical exams from two dysmorphologists; in samples 2 and 
3, only one exam. At the end of each day, after the dysmorphology assessments, a 
preliminary diagnosis of FAS, PFAS, deferred, another diagnosis, or not FASD was 
assigned by the examining physicians. Those children who received a preliminary diagnosis 
of a FASD or deferred were advanced to cognitive and behavioral testing as part of Tier III 
of the study.
2.2 Normal Controls
Candidates for normal comparison/control children were picked by random methods 
(without replacement) from the school rolls. By drawing the children from the same first 
grade population, the final control children were well matched with the subject children by 
age, sex, and general environment. Identical physical exams and cognitive/behavioral testing 
were performed on the control candidates. One hundred-ninety four (194) of the 1,278 
children entered the study randomly (see Figure 2).
2.3 Developmental Testing
Tier III developmental testing over the three samples included the following battery: 1) 
Wechsler Abbreviated Scale of Intelligence (WASI; Wechsler, 1999) was used as a measure 
of verbal, nonverbal and overall intelligence; the Digit Span, coding and mazes subtests of 
the Wechsler Intelligence Scale for Children (WISC, 3rd ed.) were used as specific measures 
of memory, processing speed and visual/planning respectively (Wechsler, 1991); the Wide 
Range Achievement Test (WRAT; Wilkinson, 1993); the Vineland Adaptive Behavior 
Scales (Classroom Edition; Sparrow et al., 2006); and the Personal Behavior Checklist 
(PBCL; Streissguth and Barr, 1998). All tests were administered by the local school staff 
psychologists blinded to all other findings in this study.
2.4 Maternal Interviews
Also in Tier III, all available mothers of the children with preliminary diagnoses of FASD or 
deferred and the mothers of control candidates who signed a second, separate consent form, 
were interviewed in person with a maternal risk factor questionnaire. One hundred and 
twenty-three (123) mothers were interviewed: 65.4% of all mothers of the FAS or PFAS 
cases, and 56.9% of the mothers of the randomly-selected, normal controls completed 
interviews. All participants received gift cards to a local store as an incentive.
The questionnaire was developed specifically for FASD epidemiology studies. 
Retrospective data collection reconstructs maternal behavior and traits before, during, and 
after gestation of the index child. While a substantial focus is on alcohol use during the 
index pregnancy, questions also include items on distal risk variables: childbearing history; 
drinking history and drinking by quantity, frequency, and timing; marital status; 
socioeconomic status (SES); and nutrition. To establish rapport, nonthreatening questions 
are asked first, and the interview moves to information on health and childbearing. Next, 
current drinking is explored via dietary intake and a 1-week, day-by-day log, as alcohol 
consumption accuracy is facilitated by this format, especially in the context of dietary 
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questions (King, 1994). Multiple measures of alcohol use before, during, and after 
pregnancy are asked, paying special attention to alcohol brands and containers used (vessels 
measurement) to calibrate amounts consumed (Kaskutas and Graves, 2000, 2001). Alcohol 
is calibrated in standard US units where one drink equals: 340 ml can/bottle of beer (5% 
ethanol), 120 ml of wine (11% ethanol), or 44 ml of distilled spirits (43% ethanol). 
Questions on current drinking are used as benchmarks to establish the method of reporting 
and for refreshing recall before the timeline follow-back questions begin (Sobell et al., 1988, 
2001). Then gestational drinking is queried. Although some studies indicate that prospective 
(prenatal) reports of one’s drinking are valid predictors of neurobehavioral outcomes 
(Jacobson et al., 2002), other studies indicate that retrospective reports of gestational alcohol 
use are accurate for a variety of other topics (Alvik, 2006; Czarnecki et al., 1990; Hannigan 
et al., 2010). All interviews were conducted by experienced interviewers, predominantly 
nurses employed by the city/county health department and subcontracted by the project.
2.5 Data Analysis
Data processing utilized EPI INFO (Dean et al., 1994) and SPSS (IBM, 2011) to compare 
groups via two-tailed statistical tests of significance with Bonferroni adjustments of alpha 
levels in the first two tables to account for possible familywise error among certain variables 
(Tabachnick and Fidell, 2013). Comparing three groups on continuous variables, one-way 
Analysis of Variance (ANOVA) was used, with Welch adjustment when homogeneity of 
variance was significantly violated at alpha = .01. Post-hoc analyses tested for significant 
differences between each of the three groups via Dunnett Pairwise comparison (C) tests 
(which compensate for highly different sample sizes and heterogeneity of variance among 
groups) at an alpha level of .05. Due to the exploratory nature of this inquiry into maternal 
risk factors in a general U.S. population, alpha level of .05 (two-tailed) was used to interpret 
significance for all maternal risk comparisons in Table 3.
3. RESULTS
3.1 Child Physical Growth Traits and Dysmorphology
Table 1 summarizes demographic and physical features of all consented children (column 
1), randomly-selected controls (column 2, n = 190), and children with final diagnoses of 
PFAS (n = 19), and FAS (n = 7). Values for the common measures of the randomly-selected 
control sample and those of consented children are similar; randomly-selected children are 
well within overall growth parameters. The children of the diagnostic categories did not 
differ significantly on sex or race/ethnicity. However, the FAS and PFAS children differed 
significantly from the randomly-selected normal controls on age, height, weight, and body 
mass index (BMI) centile, and height and weight differences were expected by definition. 
Bonferroni corrected values (p<.005) are not appropriate for these particular variables as 
they represent required diagnostic criteria. Also as planned and required by definition, 
averages for each of the key FAS clinical markers, FAS, PFAS, and controls differed 
significantly: OFC, palpebral fissure length (PFL), smooth philtrum, and narrow vermilion 
border. For other minor anomalies that are frequently found in children with FAS or PFAS, 
flat nasal bridge, heart murmur, hypertrichosis, and maxillary and mandibular arcs differed 
significantly across groups with either standard alpha levels (p<.05) or the Bonferroni 
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corrected alpha level (p<.0063). In addition, clinical assessments identified hypoplastic 
midface, clinodactyly, and camptodactyly as approaching statistical significance between 
groups. Dunnett C analyses indicated that height and weight differed significantly among all 
three groups (FAS from PFAS, FAS from controls, and PFAS from controls), OFC and PFL 
differ between both FAS and controls and PFAS and controls, and maxillary arc differs 
significantly between FAS and PFAS and FAS and controls. Total dysmorphology scores 
differ significantly across groups, and while it does not differ in an individual Dunnett 
comparison between FAS and PFAS, it is highest for the children with FAS (mean = 13.3, 
SD = 4.7), and then PFAS (mean = 11.3, SD = 3.9). Children with FAS met standard clinical 
criteria and exceeded it in many cases as they are the most dysmorphic and growth deficient, 
followed by children with PFAS.
3.2 Cognitive and Behavioral Indicators of FASD
Scores on neurodevelopment tests (Table 2 and Figure 3) are compared among children of 
the three diagnostic groups. Mean I.Q. scores were similar for FAS and PFAS groups and 
significantly lower than those for controls with both the ANOVA values and Dunnett C 
comparisons. Overall the means of 12 of the developmental and behavioral variables were 
statistically significant among groups with alpha=.05 and 11 of 13 with Bonferroni corrected 
values. Pairwise analyses revealed that the traits that most distinguish FAS and PFAS 
groups from controls were reading and communication, as both FAS and PFAS groups 
performed significantly worse than controls. Children with PFAS had the most documented 
behavioral problems, and total behavioral problems did not differ between the FAS and 
control children.
3.3 Variables of Maternal Risk for FASD
Maternal risk variables for the combined FASD diagnostic groups and randomly-selected 
controls are in Table 3. As the maternal questionnaire cast a broad net in a small sample in a 
US community, many variable comparisons did not reach statistical significance among 
groups. Mothers of children with FAS or PFAS were significantly more likely to have 
reported drinking during the index pregnancy than mothers of normal controls (75% vs 
39%). They also have significantly lower educational attainment levels than controls, are 
shorter in stature, and report finding out that they were pregnant significantly later in the 
index pregnancy (8.6 weeks, SD = 8.2) than controls (5.8, SD = 3.2), have had a sexually 
transmitted disease sometime in their life, and were more likely to report post-partum 
depression. Approaching significance at alpha = .05 were: higher gravidity, a lower 
percentage seeking prenatal care in the first trimester, and a lower use of prenatal vitamins 
for the mothers of children with a FASD. Mothers of children with FASD were significantly 
more likely to report using marijuana in addition to alcohol during pregnancy. Approaching 
significance were reports of binge drinking during the index pregnancy among mothers of 
children with FASD (100% vs. 38.5%, p=.054) and use of methamphetamines and 
painkillers without a prescription. Even though more mothers of children with FASD 
reported drinking during the index pregnancy, there were no significant differences between 
the groups on any current drinking measures (not shown in Table 3). Overall, alcohol use 
during early life and during the index pregnancy was reported to be higher for mothers of 
children with FASD: drinking regularly at an earlier age, consuming alcohol three months 
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prior to pregnancy, and drinks per drinking day during the first and second trimesters of the 
index pregnancy.
3.4 Prevalence of FASD Estimated by Three Techniques
Final diagnosis numbers and rates for the children are presented in Table 4, left section. 
Seven children were diagnosed with FAS and 19 with PFAS. With the first estimation 
technique, two denominators were used: children enrolled in 1st grade classes at all schools 
(n=2377), and the number with consent to participate in this study (n=1278). The 
assumption was that oversampling small children provided the highest probability of 
including most of the children with FAS or PFAS. The rate of FAS with this technique is 
between 2.9 and 5.5 per 1,000. PFAS is 7.9 to 14.9 per 1,000 (see Table 4).
A second rate was calculated from the 6 cases of FASD (2 FAS and 4 PFAS) found within 
the 194 children who entered the study via random selection (Table 4, middle columns). The 
estimated rates from this sample are: 10.3 FAS cases per 1,000 (95% CI = 0 to 24.5) and 
20.6 cases of PFAS per 1,000 (95% CI = .62 to 40.6). The combined FAS and PFAS rate is 
30.9 per 1,000 (95% CI = 6.6 to 55.3).
The third rate (Table 4, far right columns) was calculated from the number of cases which 
would likely have been found in the 1,099 unconsented children. Projecting the proportions 
of FAS (.0103) and PFAS (.0206) diagnoses found in the random sample (technique 2) to 
estimate the number of cases among the unconsented children (n = 1099) and adding them 
(FAS = 11 estimated cases, PFAS = 23 estimated cases) to the cases diagnosed in the 
consented population, technique 3 yields a FAS rate of 7.5, PFAS of 17.7, and a combined 
rate of 25.2 per 1,000 (95% CI=18.9 to 31.5) or 2.5% (Table 4, section 3).
From the above estimation techniques, we believe that the most accurate and empirically-
based rates for this community are: FAS 2.9 to 7.5 per 1,000 and PFAS 7.9 to 17.7 per 
1,000. The combined rate of FAS and PFAS is 10.9 to 25.2 per 1,000 or 1.1% to 2.5% 
(Figure 4).
4. DISCUSSION
Active case ascertainment methods for identifying children with lagging growth and 
development and significant dysmorphia associated with FAS and PFAS worked well in this 
population. Non-reporting or underreporting of maternal drinking, however was a greater 
challenge in this US community than encountered in South Africa, but comparable to the 
challenges in Italy and other first world countries (Alvik et al., 2006, 2005; Ceccanti et al., 
2014; Garcia-Algar et al., 2008; Manich, et al., 2012; Montag et al., 2015; Morini et al., 
2013; Wurst et al., 2008). Nevertheless, the overall profile established for mothers of the 
children with FASD is a consistent one of consistently higher risk for mothers of FASD than 
for mothers of normal controls. For the diagnostic process, both the child and maternal 
information proved to be informative and vital, and we have found many similarities to other 
populations in this RMRC sample. The early experience within the RMRC, and our findings 
overall led us to explore opportunities for larger and more comprehensive in-school studies 
in other US communities.
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4.1 Findings Common to Other US Studies
A similar study which we have completed in a representative Midwestern City produced 
similar prevalence and traits: the FAS rate was 6 to 9 children per 1,000; PFAS was 11.3 to 
17.2 per 1,000; and the FAS and PFAS combined rate was 17.2 to 26.1 per 1,000 or 1.7 to 
2.6% (May et al., 2014). The prevalence of FAS in these two studies is also comparable to, 
but somewhat higher than the three other US in-school studies cited in the introduction 
(Burd et al., 1999; Clarren et al., 2001; Poitra et al., 2003). Furthermore, the child and 
maternal risk traits in the Midwestern City are consistent with those in the RMRC study. In 
addition to the cardinal dysmorphic facial features of FAS and PFAS dictated by IOM 
criteria, a substantial number of minor anomalies that discriminate children with FASD from 
controls and are consistent between studies are reflected in the total dysmorphology score. 
The following minor anomalies haven proven to significantly distinguish children with 
FASD from normal children in our two US studies and in other, clinic-based dysmorphology 
studies in the US: diminished maxillary and mandibular arcs (other subtle measures of 
midface underdevelopment), and clinodactyly and camptodactyly of the fingers (Feldman et 
al., 2011, 2012; Jones et al., 2010).
There are also some common maternal risk factors in the two US studies: later recognition 
of pregnancy and fewer prenatal visits in the index pregnancy, substantial drinking reported 
during the 3 months prior to pregnancy, admission of drinking in 2 of 3 trimesters, and 
reports of bingeing at some time in adult life.
4.2 Maternal Risk Factors and Recruitment Issues
In both US community prevalence studies to date it was difficult to recruit mothers and to 
obtain what were believed to be accurate reports of prenatal drinking, let alone accuracy of 
quantity, frequency, and timing (QFT) of drinking. Drinking results, when compared across 
mothers of FASD and control groups, were often not statistically significant for the US 
samples, but the profile of maternal risk factors was consistently patterned in the directions 
predicted by similar, maternal risk studies elsewhere (Ceccanti et al., 2014; May et al., 2005, 
2008, 2013a; Viljoen et al. 2002). Maternal drinking studies in more candid populations 
such as among South African mothers in small towns, have proven to be far more 
discriminating among diagnostic groups and have produced more realistic reports of 
drinking QFT than encountered in US studies thus far (May et al., 2013b). Knowing that 
prenatal drinking is potentially damaging for the fetus, and the stigma that this knowledge 
produces in well-educated populations, suppresses the willingness among women to be 
forthcoming about alcohol consumption during pregnancy. It has proven to be more difficult 
to engage US mothers successfully and therefore, to assess proximal risk. QFT drinking 
measures did not discriminate the groups as well as in South Africa, but did so in a manner 
comparable to previous studies in Italy (Ceccanti et al., 2014). While the overall trajectory 
of reported drinking was in the direction predicting greater risk among the mothers of 
children with a FASD diagnosis, only some measures were significantly significant or 
approached significance. Many studies indicate, especially those that compare self-reported 
usage of alcohol to biomarker evidence, that American and European women underreport or 
deny drinking, limiting the opportunity to determine actual alcohol exposure levels to the 
fetus (Morini et al., 2013; Wurst et al., 2008).
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The less sensitive, less guilt-inducing, distal risk variables such as childbearing history, 
education, and demographic measures are more accurately reported than are drinking 
variables. However, in a well-nourished, middle SES, stable population, these distal 
variables prove to be less influential in creating risk for FASD than in low-SES, socially and 
nutritionally challenged populations. Maternal risk factors such as high gravidity, low BMI, 
poverty, and depression that are statistically significant in the less economically developed, 
binge drinking subpopulations of South Africa, were less discriminating in this US 
population and in Italy (Ceccanti et al., 2014). Abel and Hannigan (1995) referred to these 
distal co-factors of risk as permissive and provocative variables, for in the presence of the 
teratogenic agent (alcohol), they increase vulnerability of the fetus to the toxic effects of the 
agent. In South Africa they are quite influential, but in this US and Italian studies, less so.
4.3 Strengths and Weaknesses of the Study
The foremost strengths of this study were the active case ascertainment methods employed 
by using a multidisciplinary team of experts in assessing three samples of a representative 
school population. A second strength of the study was a high degree of local interest and 
engagement. A sage nurse for the city/county health department asked to have the study 
initiated in this community. After many meetings, discussions, and planning, the study was 
approved and supported enthusiastically. Third, school psychologists were pleased to have 
the opportunity to provide more cognitive and behavioral testing and developmental advice 
than would otherwise have been possible. Fourth, the administrators of the school system 
were grateful to have detailed aggregate growth and development data for their children to 
assist in monitoring growth, development, and BMI over the years.
There were also weaknesses. First, funding and time resources were limited, and field 
staffing was minimal. More staff would have helped complete more maternal interviews. 
Second, time only permitted two distributions of consent forms and limited follow-up in the 
first two samples. Even though the overall consent to participate was quite acceptable at 
53.8%, recruitment in the third sample was more effective and approached 70%. Third, 
because of lack of time and monetary resources, over-sampling of the smaller children was 
limited to those who were ≤ 10th centile on height, weight, and head circumference rather 
than ≤ 25th as we would have liked. The latter cut-off might have recruited more children 
with PFAS and allowed for exploration of the diagnosis of alcohol-related 
neurodevelopmental disorder (ARND). Limited resources and the evolutionary state of 
ARND diagnostic criteria at this time, necessitated limiting the study to FAS and PFAS. 
Finally, we could only provide limited follow-up testing and other services for a few of the 
10 equivocal cases who remained in the “deferred” category after the case conference. 
Further follow-up may have resulted in more cases of FASD and would have further 
benefitted the community and families.
Active case ascertainment methods and a comprehensive diagnostic process determined the 
prevalence and characteristics of FAS and PFAS in three first grade cohorts. Because of the 
rigor of the approach, the utilization of highly experienced clinical experts, and the 
characteristics of the population of this city, the prevalence of FAS and PFAS is greater in 
this US community than previously accepted estimates of FASD would dictate. Overall, the 
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rate of FAS is 2.9 to 7.5 per 1,000 and PFAS is 7.9 to 17.7 per 1,000. Previously popular 
rates of FAS were between 0.5 and 3.0 per 1,000 (CDC, 1995, 1997; Stratton et al., 1996). 
Not only is the rate of FAS higher in this community, but the combined rate of FAS and 
PFAS is higher (1.1 to 2.5%) than the long-standing, previous estimate for total FASD of 
1% (Sampson et al., 1997).
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• Fetal alcohol spectrum disorders (FASD) were studied in a United States 
community.
• Physical and neurobehavioral traits of children with FASD are presented.
• Maternal risk factors for FASD in this United States population are presented.
• The rate of fetal alcohol syndrome (FAS) is 2.9 to 7.5 per 1,000 children.
• Total rate of FAS and partial FAS is higher than previous estimates (1.1 to 
2.5%).
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Diagnostic Guidelines for Specific Fetal Alcohol Spectrum Disorders (FASD), According to 
the Institute of Medicine, as Clarified by Hoyme et al., 2005
1Stratton KR, Howe CJ & Battaglia FC (1996) Fetal alcohol syndrome diagnosis, 
epidemiology, prevention, and treatment. Institute of Medicine. National Academy Press, 
Washington, D.C.
2Hoyme HE, May PA, Kalberg WO, Kodituwakku P, Gossage JP, Trujillo PM, Buckley 
DG, Miller J, Khaole N, Viljoen DL, Jones KL, Robinson LK (2005) A practical clinical 
approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute 
of Medicine criteria. Pediatrics 115:39–47.
3Astley SJ, Clarren, SK (2000) Diagnosing the full spectrum of fetal alcohol-exposed 
individuals: introducing the 4-digit diagnostic code. Alcohol Alcohol 35:400–10.
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Methodology of the Rocky Mountain Region City (USA) FASD Pilot Studies with 
Sampling Procedures and Numbers
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Comparison of Developmental Tests and Behavioral Indicators of Children with FAS, 
PFAS, and Normal Controls: Rocky Mountain Region City, USA.
#All scores standardized for age of child at time of testing.
*Wechsler Abbreviated Scale of Intelligence - (WASI). (Mean score of 100 with Standard 
Deviation of 15).
+Wide Range Achievement Test Revision 3 - (WRAT). (Mean score = 100 with a Standard 
Deviation of 15).
^d. Vineland Adaptive Behavior Scales (Classroom Edition). (Mean score = 100 with a 
Standard Deviation of 15).
**Wechsler Intelligence Scale for Children 3rd edition coding, mazes and digit span subtests 
- (WISC). (Score range: 0–20).
**Personal Behavior Checklist (PBCL-36). Higher scores indicate more behavioral 
problems.
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Final Prevalence of FAS, PFAS, and the Two Diagnoses Combined among First Grade 
Children in a Rocky Mountain Region City
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